| Literature DB >> 27079197 |
Ngoot-Chin Ting1,2, Zulkifli Yaakub1, Katialisa Kamaruddin1, Sean Mayes3, Festo Massawe2, Ravigadevi Sambanthamurthi1, Johannes Jansen4, Leslie Eng Ti Low1, Maizura Ithnin1, Ahmad Kushairi1, Xaviar Arulandoo5, Rozana Rosli1, Kuang-Lim Chan1, Nadzirah Amiruddin1, Kandha Sritharan5, Chin Ching Lim5, Rajanaidu Nookiah1, Mohd Din Amiruddin1, Rajinder Singh6.
Abstract
BACKGROUND: The commercial oil palm (Elaeis guineensis Jacq.) produces a mesocarp oil (commonly called 'palm oil') with approximately equal proportions of saturated and unsaturated fatty acids (FAs). An increase in unsaturated FAs content or iodine value (IV) as a measure of the degree of unsaturation would help to open up new markets for the oil. One way to manipulate the fatty acid composition (FAC) in palm oil is through introgression of favourable alleles from the American oil palm, E. oleifera, which has a more unsaturated oil.Entities:
Keywords: Backcross-two (BC2); Elaeis guineensis; Elaeis oleifera; Iodine value (IV); Oleic acid (C18:1); Palmitic acid (C16:0)
Mesh:
Substances:
Year: 2016 PMID: 27079197 PMCID: PMC4832457 DOI: 10.1186/s12864-016-2607-4
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1The OxG mapping population and BC2 validation crosses used in this study. The 108 OxG interpecific hybrids (left) were created by crossing a maternal Colombian E. oleifera (UP1026) with a paternal palm T128 (tenera), from the Nigerian germplasm. The same T128 palm was also used in creating the BC2 validation crosses (right). The La Mé E. guineensis (L2T, maternal parent) was crossed with a Colombian E. oleifera (79/4.4–12/6.61, paternal parent) and the resulting GxO F1 hybrid (983/2.4–43/15.90) was then backcrossed with the T128 palm to produce the BC1. Pollen from a selected BC1 palm (335/5.2–5/23.96) was used to cross-pollinate two E. guineensis palms. The first E. guineensis (1084/TP51/22.32) was derived from a cross between the T128 and a Serdang pisifera and the second palm (320/TT113/22.32) was derived from a self-pollination of the T128 palm. The two BC2 families namely, 2.6–1 and 2.6–5 consisted of 74 and 80 palms, respectively
Summary of phenotypic data in the OxG mapping population and two BC2 (2.6-1 and 2.6–5) validation crosses
| Trait | OxG ( | 2.6–1 ( | 2.6–5 ( | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean (% ± SD) | Variance | Range (%) | Mean (% ± SD) | Variance | Range (%) | Mean (% ± SD) | Variance | Range (%) | |
| Iodine value (IV) | 70.98 (±2.88) | 8.28 | 65.25–77.33 | 65.13 (±2.55) | 6.51 | 60.19–69.86 | 63.44 (±3.24) | 10.46 | 57.12–71.60 |
| Myristic acid (C14:0) | 0.29 (±0.09) | 0.01 | 0.14–0.55 | 0.27 (±0.08) | 0.007 | 0.14–0.49 | 0.43 (±0.14) | 0.02 | 0.17–0.75 |
| Palmitic acid (C16:0) | 29.22 (±3.07) | 9.45 | 22.25–34.33 | 31.06 (±0.08) | 6.08 | 24.73–36.68 | 35.29 (±2.86) | 8.15 | 26.85–41.69 |
| Palmitoleic acid (C16:1) | 0.43 (±0.14) | 0.02 | 0.20–0.83 | 0.12 (±0.02) | 0.000 | 0.07–0.16 | 0.18 (±0.06) | 0.003 | 0.08–0.34 |
| Stearic acid (C18:0) | 2.08 (±0.32) | 0.10 | 1.50–3.10 | 6.15 (±1.31) | 1.73 | 3.29–9.43 | 3.79 (±0.93) | 0.86 | 2.11–6.48 |
| Oleic acid (C18:1) | 53.96 (±3.19) | 10.20 | 48.20–61.45 | 48.61 (±2.87) | 8.25 | 40.92–57.18 | 47.08 (±3.68) | 13.55 | 37.58–54.48 |
| Linoleic acid (C18:2) | 12.76 (±0.91) | 0.82 | 10.45–15.15 | 12.86 (±1.41) | 1.98 | 9.60–16.29 | 12.67 (±2.07) | 4.27 | 8.15–17.65 |
| Linolenic acid (C18:3) | 0.50 (±0.08) | 0.01 | 0.40–0.65 | 0.36 (±0.06) | 0.004 | 0.16–0.49 | 0.22 (±0.15) | 0.02 | 0–0.53 |
Means (%), ranges and variances measured for iodine value and various fatty acid contents in palm oil
Fig. 2QTL profiles linked to IV and FAC on the improved genetic linkage map of OxG. The graphs (a – f) present QTLs (represented by different colour lines) significant at 95 % genome-wide (GW) and chromosome-wide (CW) thresholds in linkage groups (LGs) OT1, T9, OT4, T2, T3 and OT6
Fig. 3Distribution of phenotypes categorized based on the genotypes of the closest markers linked to the observed QTLs in LGT9. The upper panel (light grey) is of hybrids with genotype ab (aa) while the lower panel (dark grey) shows the phenotypes observed in genotype aa (ab) in SNPM00331 (SNPM00922) for C16:1 (a) and C18:0 (b) and, SNPM00343 for C14:0 (c)
QTLs linked to iodine value (IV) and fatty acid composition (FAC) in the OxG interspecific mapping population. QTLs identified using Interval Mapping (IM), the Multiple-QTL Model (MQM), the Kruskal-Wallis non-parametric tests (KW) and G Model (GM)
| Trait | IM | MQM | KW | GM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| QTL interval (cM) | QTL peak (cM) | QTL peak (LOD) | Closest marker | Var (%) | LOD | Var (%) | K-value |
| Marker effect |
| |
| IV (GW = LOD4.3) | |||||||||||
| OT1a | 102.3–151.5 | 149.6 | 17.4 | SNPM04501 | 60.8 | 17.6 | 61.2 | 51.1 | 0.0001 | 2.16 (+) | 0.0000000 |
| SNPM00967 | 2.16 (+) | 0.0000000 | |||||||||
| SNPM00144 | 2.16 (+) | 0.0000000 | |||||||||
| SNPM01034 | 2.16 (−) | 0.0000000 | |||||||||
| SNPM00150 | 2.16 (−) | 0.0000000 | |||||||||
| PA5_oSSRa | 2.15 (−) | 0.0000000 | |||||||||
| PA3_oSSRa | 2.18 (−) | 0.0000000 | |||||||||
| SNPE00431 | 2.17 (+) | 0.0000000 | |||||||||
| sPSc00328a | 2.15 (+) | 0.0000000 | |||||||||
| C14:0 (GW = LOD3.7) | |||||||||||
| OT1a | 140.7–151.5 | 149.6 | 6.2 | SNPM04501 | 48.3 | 5.7 | 26.5 | 24.9 | 0.0001 | 0.04 (−) | 0.0000000 |
| SNPM00967 | 0.04 (−) | 0.0000000 | |||||||||
| SNPM00144 | 0.04 (−) | 0.0000000 | |||||||||
| SNPM01034 | 0.04 (+) | 0.0000000 | |||||||||
| SNPM00150 | 0.04 (+) | 0.0000000 | |||||||||
| PA5_oSSRa | 0.04 (+) | 0.0000000 | |||||||||
| PA3_oSSRa | 0.04 (+) | 0.0000000 | |||||||||
| SNPE00431 | 0.04 (−) | 0.0000000 | |||||||||
| sPSc00328a | 0.04 (−) | 0.0000000 | |||||||||
| T2 | 61.2–62.1 | 61.2 | 4.1 | SNPM04068 | 20.1 | 4.3 | 22.9 | 15.1 | 0.0005 | 0.03 (+) | 0.0000000 |
| SNPM01906 | 0.03 (+) | 0.0000000 | |||||||||
| SNPM04410 | 0.03 (−) | 0.0000000 | |||||||||
| T9 | 17.2–32.6 | 17.2 | 4.5 | SNPM00343 | 21.9 | 4.0 | 21.5 | 17.7 | 0.0001 | 0.03 (−) | 0.0000000 |
| C16:0 (GW = LOD4.9) | |||||||||||
| OT1a | 102.3–151.5 | 149.6 | 21.5 | SNPM04501 | 69.4 | 22.3 | 70.2 | 55.2 | 0.0001 | 2.41 (−) | 0.0000000 |
| SNPM00967 | 2.41 (−) | 0.0000000 | |||||||||
| SNPM00144 | 2.42 (−) | 0.0000000 | |||||||||
| SNPM01034 | 2.41 (+) | 0.0000000 | |||||||||
| SNPM00150 | 2.41 (+) | 0.0000000 | |||||||||
| PA5_oSSRa | 2.37 (+) | 0.0000000 | |||||||||
| PA3_oSSRa | 2.35 (+) | 0.0000000 | |||||||||
| SNPE00431 | 2.42 (−) | 0.0000000 | |||||||||
| sPSc00328a | 2.40 (−) | 0.0000000 | |||||||||
| C16:1 (GW = LOD4.3) | |||||||||||
| T9 | 2.9–32.6 | 22.0 | 10.7 | SNPM00331 | 44.2 | 10.7 | 44.2 | 36.0 | 0.0001 | 0.08 (−) | 0.0000000 |
| SNPM00922 | 0.08 (+) | 0.0000000 | |||||||||
| C18:0 (GW = LOD3.8) | |||||||||||
| OT1a | 140.7–151.5 | 151.1 | 6.4 | sPSc00314a | 30.5 | 6.8 | 30.9 | 22.1 | 0.0001 | 0.14 (−) | 0.0000001 |
| OT4 | 158.4–176.5 | 165.1 | 4.9 | SNPM00121 | 54.2 | 4.8 | 23.5 | 16.6 | 0.0001 | 0.02 (+) | 0.0000020 |
| T9 | 13.4–24.8 | 22.0 | 5.0 | SNPM00331 | 23.8 | 5.0 | 23.8 | 19.0 | 0.0001 | 0.03 (+) | 0.0000003 |
| SNPM00922 | 0.03 (−) | 0.0000005 | |||||||||
| C18:1 (GW = LOD4.0) | |||||||||||
| OT1a | 112.6–151.5 | 149.6 | 16.3 | SNPM04501 | 59.5 | 16.9 | 60.1 | 49.5 | 0.0001 | 2.29 (+) | 0.0000000 |
| SNPM00967 | 2.17 (+) | 0.0000000 | |||||||||
| SNPM00144 | 2.18 (+) | 0.0000000 | |||||||||
| SNPM01034 | 2.17 (−) | 0.0000000 | |||||||||
| SNPM00150 | 2.29 (−) | 0.0000000 | |||||||||
| PA5_oSSRa | 2.39 (−) | 0.0000000 | |||||||||
| PA3_oSSRa | 2.06 (−) | 0.0000000 | |||||||||
| SNPE00431 | 2.07 (+) | 0.0000000 | |||||||||
| sPSc00328a | 2.30 (+) | 0.0000000 | |||||||||
| C18:2 (GW = LOD3.8) | |||||||||||
| T3 (CW = LOD1.7) | 46.9–65.2 | 63.3 | 2.1 | SNPM00462 | 10.9 | 2.3 | 11.5 | 8.9 | 0.0050 | 0.17 (+) | 0.0017218 |
| OT6 (CW = LOD2.7) | 38.9–54.5 | 45.8 | 3.1 | SNPM05061 | 35.2 | 3.3 | 40.2 | 11.0 | 0.0010 | 0.16 (−) | 0.0000052 |
aAfter fine mapping
GW: 95 % Genome-wide significant LOD threshold
CW: 95 % Chromosome-wide significant LOD threshold
Fig. 4Fine-mapping of QTL intervals with candidate markers and cross-validation of QTLs in two independent BC2 crosses. Similar QTLs between LGOT1 (OxG mapping population) and LGs 1 and 1b of BC2 validation crosses (2.6–1 and 2.6–5) are indicated by common markers (in red) and candidate SSR markers (in blue)
Fig. 5Distribution of IV and FAC phenotypes in OxG hybrids genotyped by the closest markers linked to the QTLs on LGOT1. The upper panel (light grey) is of hybrids with genotype ab (aa) while the lower panel (dark grey) shows the phenotypic distribution of genotype aa (ab) in SNPM04501, SNPM00967, sPSc00328, SNPM00144 or SNPE00431 (SNPM01034, SNPM00150, PA5_oSSR or PA3_oSSR) for IV (a), C18:1 (b), C16:0 (c) and C14:0 (d). For C18:0 (e), the ab and aa genotypes are observed in sPSc00314